207 related articles for article (PubMed ID: 30773766)
1. The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study.
Haring MPD; Gouw ASH; de Haas RJ; Cuperus FJC; de Jong KP; de Meijer VE
Liver Int; 2019 May; 39(5):905-913. PubMed ID: 30773766
[TBL] [Abstract][Full Text] [Related]
2. Regression of hepatocellular adenomas and systemic inflammatory syndrome after cessation of estrogen therapy.
Sinclair M; Schelleman A; Sandhu D; Angus PW
Hepatology; 2017 Sep; 66(3):989-991. PubMed ID: 28295483
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study on timing of resection of hepatocellular adenoma.
Klompenhouwer AJ; Bröker MEE; Thomeer MGJ; Gaspersz MP; de Man RA; IJzermans JNM
Br J Surg; 2017 Nov; 104(12):1695-1703. PubMed ID: 28857134
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
[TBL] [Abstract][Full Text] [Related]
5. Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
Vernuccio F; Ronot M; Dioguardi Burgio M; Cauchy F; Choudhury KR; Dokmak S; Soubrane O; Valla D; Zucman-Rossi J; Paradis V; Vilgrain V
Radiology; 2020 May; 295(2):361-372. PubMed ID: 32181728
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma.
Klompenhouwer AJ; Alblas M; van Rosmalen BV; Haring MPD; Venema E; Doukas M; Thomeer MGJ; Takkenberg RB; Verheij J; de Meijer VE; van Gulik TM; Lingsma HF; de Man RA; Ijzermans JNM
Am J Gastroenterol; 2019 Aug; 114(8):1292-1298. PubMed ID: 30920416
[TBL] [Abstract][Full Text] [Related]
7. Growth of hepatocellular adenoma during pregnancy: A prospective study.
Gaspersz MP; Klompenhouwer AJ; Broker MEE; Thomeer MGJ; van Aalten SM; Steegers E; Terkivatan T; de Koning H; de Man RA; Ijzermans JNM
J Hepatol; 2020 Jan; 72(1):119-124. PubMed ID: 31550458
[TBL] [Abstract][Full Text] [Related]
8. Changing trends in malignant transformation of hepatocellular adenoma.
Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
[TBL] [Abstract][Full Text] [Related]
9. Management and outcome of hepatocellular adenoma with massive bleeding at presentation.
Klompenhouwer AJ; de Man RA; Thomeer MG; Ijzermans JN
World J Gastroenterol; 2017 Jul; 23(25):4579-4586. PubMed ID: 28740346
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.
Rooks JB; Ory HW; Ishak KG; Strauss LT; Greenspan JR; Hill AP; Tyler CW
JAMA; 1979 Aug; 242(7):644-8. PubMed ID: 221698
[TBL] [Abstract][Full Text] [Related]
11. Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation.
Demory A; Péron JM; Calderaro J; Selves J; Mokrane FZ; Amaddeo G; Paradis V; Ziol M; Sutter O; Blaise L; Ganne-Carrié N; Vilgrain V; Cauchy F; Zucman-Rossi J; Ronot M; Nault JC
Hepatology; 2023 Feb; 77(2):430-442. PubMed ID: 35980227
[TBL] [Abstract][Full Text] [Related]
12. Management of Hepatocellular Adenoma: Recent Advances.
Agrawal S; Agarwal S; Arnason T; Saini S; Belghiti J
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1221-30. PubMed ID: 24909909
[TBL] [Abstract][Full Text] [Related]
13. Evidence of good prognosis of hepatocellular adenoma in post-menopausal women.
Klompenhouwer AJ; Sprengers D; Willemssen FE; Gaspersz MP; Ijzermans JN; De Man RA
J Hepatol; 2016 Dec; 65(6):1163-1170. PubMed ID: 27524464
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China.
Wang H; Yang C; Rao S; Ji Y; Han J; Sheng R; Zeng M
Eur J Radiol; 2018 Mar; 100():135-141. PubMed ID: 29496071
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for bleeding in hepatocellular adenoma.
Bieze M; Phoa SS; Verheij J; van Lienden KP; van Gulik TM
Br J Surg; 2014 Jun; 101(7):847-55. PubMed ID: 24760723
[TBL] [Abstract][Full Text] [Related]
16. Regression of multiple hepatocellular adenomas after cessation of oral contraceptive pills: a case report and review of the current literature.
Moors G; Poels H; Vandecaveye V; Roskams T; Verslype C
Acta Gastroenterol Belg; 2021; 84(3):505-508. PubMed ID: 34599577
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular adenoma: An unsolved diagnostic enigma.
Renzulli M; Clemente A; Tovoli F; Cappabianca S; Bolondi L; Golfieri R
World J Gastroenterol; 2019 May; 25(20):2442-2449. PubMed ID: 31171888
[TBL] [Abstract][Full Text] [Related]
18. Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study.
Qureshy Z; Lokken RP; Kakar S; Grab J; Mehta N; Sarkar M
Contraception; 2023 Mar; 119():109915. PubMed ID: 36476331
[TBL] [Abstract][Full Text] [Related]
19. Behavior and complications of hepatocellular adenoma during pregnancy and puerperium: a retrospective study and systematic review.
Haring MPD; Spijkerboer CS; Cuperus FJC; Duiker EW; de Jong KP; de Haas RJ; de Meijer VE
HPB (Oxford); 2021 Aug; 23(8):1152-1163. PubMed ID: 33985906
[TBL] [Abstract][Full Text] [Related]
20. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
Herman P; Machado MA; Volpe P; Pugliese V; Vianna MR; Bacchella T; Machado MC; Pinotti HW
Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):30-3. PubMed ID: 8029613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
